✦ LIBER ✦

In vitro protein-binding characteristics of atevirdine and its N-dealkylated metabolite

✍ Scribed by Lisa M Rosser; Alice M O'Donnell; Kelly M Lee; Gene D Morse

Book ID: 118393339
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 496 KB
Volume: 25
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90003-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro protein-binding characteristics

In vitro protein-binding characteristics of delavirdine and its N-dealkylated metabolite

✍ Alan J Chaput; Robin D'Ambrosio; Gene D Morse 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Analysis of buprenorphine and its n-deal

Analysis of buprenorphine and its n-dealkylated metabolite in plasma and urine by selected-ion monitoring

✍ Ylva Blom; Ulf Bondesson; Erik Änggård 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 584 KB

The pharmacokinetics of nitazoxanide act

The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in vitro

✍ Z. ZHAO; F. XUE; L. ZHANG; K. ZHANG; C. FEI; W. ZHENG; X. WANG; M. WANG; Z. ZHAO 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Liquid chromatography–mass spectrometric

Liquid chromatography–mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma

✍ Hongfei Yue; Michael R. Borenstein; Susan A. Jansen; Robert B. Raffa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

In Vitro Embryotoxicity Study of N,N-Dim

In Vitro Embryotoxicity Study of N,N-Dimethylacetamide and its Main Metabolite N-Monomethylacetamide

✍ E Menegola; M.L Broccia; M Prati; E Giavini 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Comparative class 1 electrophysiologic a

Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans

✍ Lennart Bergfeldt; Karin Schenck-Gustafsson; Rune Dahlqvist 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 860 KB

During steady-state treatment with disopyramide, its main and active metabolite, mono-N-dealkylated disopyramide, was reported to reach concentrations that were equal to or higher than the parent drug in 25% of 70 evaluated patients. This metabolite has been found to have a more pronounced anticholi